My favorite Beats earbuds are at their lowest price in 2025
All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission.
SAVE $31: As of May 14, Beats Fit Pro are on sale for $168.95 at Amazon. That's a 16% saving on the list price.
Opens in a new window
Credit: Beats
Beats Fit Pro
$168.95 at Amazon $199.95 Save $31
Get Deal
If you want a quality pair of earbuds for a great price, Beats is always a good choice. And the best of the bunch for me, the Beats Fit Pro, are on sale at Amazon for their lowest price this year.
As of May 14, you can save 16% on these earbuds, reduced to $168.95. This deal is specific to just the stone purple. However, for just $1 extra, you have the option of black, white, and sage grey.
SEE ALSO: The 9 best earbuds to buy in 2025 from Bose, Sony, and more
With these earbuds, you'll get sound quality that is second to none. It's incredibly immersive, not to mention powerful, and some of the best I've experienced. The noise cancellation modes are stellar, with several options on how much you want to block out surrounding noises (full cancellation, transparency, etc). This is great for outdoor activities such as running when you want to hear your music but also stay aware of those around you.
They also boast a seriously impressive battery life, with a single charge lasting days (often weeks). And for those who want to use these for sports, they're a great option. The silicon tip slides into your ear seamlessly, lodging in your ear and staying put for all types of activity at all intensities. I've tested these during many sports with varying degrees of intensity, and they always stay firmly in place.
This is a limited-time deal at Amazon, so don't miss out.
Roku Ultra 4K Ultimate Streaming Player (2024 Release) — $79.99 (List Price $99.99)
Beats Pill Bluetooth Speaker — $99.95 (List Price $149.00)
Roborock Qrevo Master Robot Vacuum and Mop — $799.98 (List Price $1599.99)
Peloton Bike — $1,145.00 (List Price $1445.00)
Apple AirTag (4-Pack) — $79.98 (List Price $99.00)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
UK's GCA to probe Amazon for alleged delays in supplier payments
UK's GCA launches probe into Amazon alleged delays in supplier payments The UK's Groceries Code Adjudicator (GCA) has initiated a probe into Amazon after concerns about alleged potential violations of regulations governing the timely payment to suppliers. The inquiry stems from suspicions that Amazon may have violated paragraph 5 of the code (no delay in payments) between 1 March 2022 and 20 June 2025. It will particularly scrutinise practices since 1 January 2024 to gain a comprehensive understanding of Amazon's current procedures. The investigation will assess the extent of any breaches, their impact on suppliers and the underlying causes. The GCA will examine Amazon's practices related to receiving goods, payment processes, handling supplier concerns about payment deductions and the use of settlements od deductions in its commercial negotiations. The GCA's decision to investigate follows previous interactions with Amazon. Mark White, the adjudicator, informed Amazon in 2024 that it must take decisive action to adhere to the code. White stated: 'Delays in payment can significantly harm suppliers. The alleged delays could expose Amazon suppliers to excessive risk and unexpected costs, potentially affecting their ability to invest and innovate. 'I decided to launch this targeted investigation based on the range of evidence I have seen from multiple sources. It will allow me to determine whether Amazon has breached paragraph 5 of the Groceries Code and the root cause of any breach.' The GCA states that despite Amazon's subsequent efforts, further detailed evidence from suppliers requires targeted investigation into payment practices. Reports have been received of other Groceries Code issues at Amazon. The GCA continues to work with Amazon to resolve these matters and remains prepared to initiate further investigations if required. White has called upon direct suppliers and stakeholders to contribute evidence and share their experiences of supplying to Amazon, as part of the GCA's evidence-gathering process for the ongoing investigation, stating: 'All responses will be completely confidential.' In June 2025, Amazon announced plans to downsize its corporate staff as it integrates generative AI technology into its business processes. "UK's GCA to probe Amazon for alleged delays in supplier payments" was originally created and published by Retail Insight Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Amazon's Driverless Cab Company Zoox Revs Up ‘Toaster Taxis'
Amazon hopes ride-hailers love direct eye contact because its carriage-style robotaxis feature four seats facing each other. After cutting the ribbon on a new factory in California, Amazon is ramping up production of its bidirectional, self-driving cabs ahead of a planned launch in Las Vegas later this year. The Bay Area facility currently churns out one robotaxi a day, but Zoox hopes to boost that rate to three an hour by next year. After buying Zoox five years ago for $1.3 billion, Amazon is prepping a big push onto the roads of major cities (first, Las Vegas and later, San Francisco, Austin and Miami). But rivals are already there. READ ALSO: Cybersecurity Giant Palo Alto Networks Caught Between Opportunity and Maturity and 'Uncertain' 2025, M&A Deadlock Freeze $1 Trillion in PE Assets Alphabet's Waymo said it provides 250,000 rides a week in its self-driving cabs, up from 10,000 two years ago. Riders can hail a driverless Jaguar from Waymo's app in Austin, Los Angeles, Phoenix and San Francisco. Waymo also recently applied for a permit to operate in New York City, where state law will require a driver, though the company is pushing to change that provision. So far, Waymo is the only fully operational self-driving taxi service in the US, but Tesla is trying to join it ASAP: CEO Elon Musk promised in 2021 that Tesla would have a million robotaxis on the road by now, which … didn't happen. Tesla did, however, put a small group of robotaxis on the road in Austin, Texas, last weekend, which Musk described in a virtual victory lap as 'the culmination of a decade of hard work.' Regulators are investigating Tesla's self-driving tech in connection with fatal accidents as critics raise red flags about its robotaxi's lack of lidar and radar, which Waymo and Zoox use. Waymo and Zoox have been investigated after incidents including erratic driving. Yellow Light. Zoox is trying to join a race that Waymo's already a few laps into, but Waymo may have made the road a little smoother. Waymo eased riders into the concept of driverless taxis with its fleet of Jaguars, which look like regular cars with some extra gadgets whirring around. Zoox's autonomous taxis don't even have a steering wheel, so Zoox has planned a marketing push to persuade riders to hop into its toaster taxis. What'll probably be more important for swaying would-be riders is how safe upcoming robotaxi rollouts are. This post first appeared on The Daily Upside. To receive delivering razor sharp analysis and perspective on all things finance, economics, and markets, subscribe to our free The Daily Upside newsletter.
Forbes
an hour ago
- Forbes
GenAI Won't Replace Doctors, But It Could Make Them Miserable
No matter how powerful generative AI becomes, physicians will still have jobs. But will those jobs ... More be fulfilling or soul-crushing? Will AI replace doctors? A year ago, most physicians would've confidently answered 'no.' Medicine, they'd argue, is too complex, too personal, too human to be handled by machines, no matter how advanced. Now, that confidence is starting to waver. Physicians, like other highly educated workers, are watching what's happening in another once-secure, intellectually demanding profession: computer programming. Not long ago, coding was considered one of the most prestigious and future-proof careers in the modern economy. The brightest students pursued software engineering, drawn by high salaries, strong demand and the appeal of solving complex problems. Programmers were irreplaceable. Until they weren't. From Amazon to Meta to Salesforce, tech companies are laying off engineers by the thousands. At Microsoft, generative AI already writes a third of the company's code, and some experts predict it could eliminate two-thirds of programming jobs by decade's end. Companies like Shopify and IBM have gone even further, requiring managers to justify hiring humans over AI or freezing new hires for roles they believe GenAI tools will soon replace. In medicine, large language models already outperform physicians at diagnosing complex cases and answering patient questions. But that doesn't mean clinicians are at risk of losing their jobs. Here are three reasons GenAI won't replace doctors — followed by one major caveat. 1. Too Few Doctors, Too Much Work Across hospitals and clinics, American healthcare is already stretched beyond capacity. The American Medical Association projects a shortfall of up to 124,000 physicians by 2036, including 48,000 in primary care alone. Three major forces are driving this shortage: Bottom line: The physician shortage is real and getting worse. GenAI can help fill the gaps, but it won't eliminate the demand for human clinicians. 2. Cutting Doctors Is A Poor Way To Cut Costs In most industries, replacing high-salaried workers with technology is the fastest path to profitability. But in healthcare, that approach misses the point entirely. Take primary care as an example. It's the backbone of the U.S. medical system, yet it accounts for less than 5% of the nation's $4.9 trillion in healthcare spending. Only half of that percentage goes to salaries. So, even if we eliminated half of all primary care physicians (an unthinkable move), total costs would drop by just 1.25%. In healthcare, the greatest opportunity for cost savings is in preventing and better managing chronic diseases like diabetes, hypertension and long-term heart failure. According to the CDC, improving prevention and chronic disease management could prevent 30–50% of their complications (heart attack, stroke, cancer and kidney failure). Avoiding these catastrophic medical events would save an estimated $1.5 trillion annually. Value-based care models have already demonstrated what's possible. Studies from leading health systems show that investing in proactive, team-based primary care reduces hospitalizations, improves outcomes and lowers annual per-patient costs by up to 23%. That's where the right combination of clinicians and generative AI offers the greatest value. Between visits, GenAI can track symptoms, alert patients to necessary medication changes and identify complications before they turn into crises. Paired with 24/7 telemedicine, GenAI can provide patients with real-time expertise and care for routine concerns, flagging serious problems when doctors aren't normally available. Bottom line: Controlling chronic disease offers 20 times the savings of cutting primary care jobs. Ultimately, the greatest cost reductions will come from better health, and the best way to achieve that is pairing generative AI with skilled clinicians and empowered patients. 3. AI Can't Replace Human Connection Generative AI is becoming more skilled with every update. In a recent dual study, ChatGPT provided answers to routine patient questions originally fielded by doctors. When clinicians and patients reviewed the anonymized responses, the AI was rated better than physicians in both quality and empathy. But when the stakes are high — life-altering cancer diagnoses or complex treatment decisions —patients want a trusted human at their side. Abraham Verghese, my colleague at Stanford and a bestselling author, notes: 'Medicine at its heart is a human endeavor … the physician‑patient relationship is key; all else follows from it.' He emphasizes the ritual of the physical exam as transformative, a structured encounter that seals trust, communicates care and calms fear. Studies show that the doctor's touch reduces anxiety, boosts patient satisfaction, and even improves clinical outcomes. Bottom line: Even when data show that generative AI is more accurate, patients still want to talk with a human when facing complex or life-threatening decisions. A Caution Against Complacency No matter how powerful generative AI becomes, physicians will still have jobs. But will those jobs be fulfilling or soul-crushing? That depends on what doctors do next. If private equity firms or for-profit health insurers determine how GenAI is integrated into medicine, the technology will be used primarily to increase productivity: faster diagnoses, shorter visits, less support staff. Yes, technology can streamline tasks. But unless clinicians shape its deployment, GenAI will be used primarily to drive productivity, making today's problems worse for both clinicians and patients. By contrast, if physicians take the lead, they can harness generative AI to improve patient health, reduce burnout and lower costs by preventing complications like heart attacks, strokes, cancer and kidney failure. But that success will require more than technological tools. Doctors must organize into high-performing medical groups, integrate GenAI into all aspects of clinical care and negotiate payment models that reward improved outcomes — not just higher volume. Bottom line: Bottom line: GenAI can cut corners or improve care, but not both. It can boost profits or improve lives, but not both. The path we take will depend on who takes the lead.
